BRD4-targeted therapy ABBV-744 clinical data No Further a Mystery
These side effects ended up notably milder as compared to an inhibitor of both equally bromodomains. An in depth molecular Evaluation also uncovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ― Stephen Taylor- Participant consumed grapefruit or grapefruit products within three days before the